Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

  • There is currently no data for ALGW

New Accounting Reference Date

23 Dec 2024 16:03

RNS Number : 1765R
Alpha Growth PLC
23 December 2024
 

 

Alpha Growth plc

("Alpha" or the "Company")

Change of Accounting Reference Date

 

Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in life insurance-linked wealth and asset management, announces that it has changed its year end to 31 March 2025. Accordingly, the next audited financial statements for the Company will be prepared for the 15-month period ending 31 March 2025 and will be required to be released by 31 July 2025.

The Directors have determined that this change will provide the incoming auditors with sufficient time to complete their on-boarding process and plan for the upcoming audit. Directors also believe that moving away from a calendar year-end will mean that the auditors will avoid the traditional calendar year end audit pressures and be able to allocate sufficient resources to the Company and its subsidiaries.

In accordance with the Listing Rules, the Company will issue a set of unaudited interim financials covering the 12-month period to 31 December 2024, on or before 31 March 2025.

** ENDS **

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

Allenby Capital Limited

+44 (0) 20 3328 5656

Amrit Nahal (Sales and Corporate Broking)

Nick Athanas / Piers Shimwell (Corporate Finance)

 

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NARQXLFLZLLBFBF
Date   Source Headline
28th Sep 20227:00 amRNSAppointment as Investment Manager/Insurance Update
12th Sep 20222:06 pmRNSSecond Price Monitoring Extn
12th Sep 20222:00 pmRNSPrice Monitoring Extension
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSDirector and Personnel Announcement
3rd Aug 20227:00 amRNSHolding(s) in Company
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20224:03 pmRNSResults of the Annual General Meeting
31st May 20227:00 amRNSRelease of 2021 Annual Report
27th Apr 20227:00 amRNSShareholder Information Update
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSAcquisition and Insurance Business Update
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
7th Mar 202211:06 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBusiness Update - 2022 Focus and the 2B Plan
21st Feb 20227:00 amRNSAppointment of new Strategic Advisor
2nd Feb 20227:00 amRNSBlackOak Alpha Growth Fund 2021 Year End Results
20th Dec 20217:00 amRNSPublication of a Prospectus
17th Dec 20217:00 amRNSChange of Adviser
13th Dec 20216:14 pmRNSHolding(s) in Company
29th Oct 202112:00 pmRNSInterim Results for Extension in Accounting Period
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20214:40 pmRNSSecond Price Monitoring Extn
19th Jul 20214:35 pmRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSTrading Update Q2 2021
6th Jul 20218:00 amRNSChange of Year End
16th Jun 20217:00 amRNSClarification of News
15th Jun 202111:05 amRNSSecond Price Monitoring Extn
15th Jun 202111:00 amRNSPrice Monitoring Extension
15th Jun 20219:05 amRNSSecond Price Monitoring Extn
15th Jun 20219:00 amRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSHolding(s) in Company
7th Jun 20217:00 amRNSWarrants Exercise and Admission Date
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20214:00 pmRNSInterim Results
19th May 20217:00 amRNSExercise of Warrants and Total Voting Rights
14th May 20217:00 amRNSHolding(s) in Company
13th May 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.